Presentation is loading. Please wait.

Presentation is loading. Please wait.

Allogeneic Hematopoietic Cell Transplantation (HCT) Results in Better Time to Next Therapy (TTNT) Than Chemotherapy (CT) in Chronic Lymphocytic Leukemia.

Similar presentations


Presentation on theme: "Allogeneic Hematopoietic Cell Transplantation (HCT) Results in Better Time to Next Therapy (TTNT) Than Chemotherapy (CT) in Chronic Lymphocytic Leukemia."— Presentation transcript:

1 Allogeneic Hematopoietic Cell Transplantation (HCT) Results in Better Time to Next Therapy (TTNT) Than Chemotherapy (CT) in Chronic Lymphocytic Leukemia (CLL)  Carlos H. Silva Rondon, MD, Thomas Whitton, Basem M. William, MD, Stan L. Gerson, MD, Brenda Cooper, MD, Hillard M. Lazarus, MD, Marcos de Lima, MD, Paolo Caimi, MD  Biology of Blood and Marrow Transplantation  Volume 22, Issue 3, Pages S210-S211 (March 2016) DOI: /j.bbmt Copyright © Terms and Conditions

2 Figure 1 Overall survival after alloHCT and chemotherapy Lines 1-4.
Biology of Blood and Marrow Transplantation  , S210-S211DOI: ( /j.bbmt ) Copyright © Terms and Conditions

3 Figure 2 Time to next therapy after alloHCT and chemotherapy lines 1-4, with death accounted as competing risk. Biology of Blood and Marrow Transplantation  , S210-S211DOI: ( /j.bbmt ) Copyright © Terms and Conditions


Download ppt "Allogeneic Hematopoietic Cell Transplantation (HCT) Results in Better Time to Next Therapy (TTNT) Than Chemotherapy (CT) in Chronic Lymphocytic Leukemia."

Similar presentations


Ads by Google